Table 2.

Cell cycle analysis after OBP-301 infection in human lung cancer cells

Cell linesTreatmentCell cycle
G1 (%)S (%)G2 (%)
H460Mock43.5443.858.61
OBP-30110.9156.4132.54
H322Mock4046.7210.85
OBP-30127.4967.093.23
H358Mock45.8938.2214.29
OBP-30128.9357.6711.45

NOTE: H460, H322, and H358 cell lines were treated with OBP-301 at 40, 100, and 80 MOI, respectively. Cells were then subjected to cell cycle analysis at 24 h after treatment by the fluorescence-activated cell sorting method. The percentages of cells in the G1, S, and G2 phases are shown.